Why the study?
How should multimodality imaging be used to assess prosthetic heart valve dysfunction?
How should multimodality imaging be used to assess prosthetic heart valve dysfunction?
Provides updated, multi-society endorsed recommendations for the multimodality imaging assessment of prosthetic heart valves.
Informs clinical protocols for prosthetic valve imaging now; extends prior guidance via multi-society consensus on echocardiography-first multimodality use.
Prosthetic heart valve (PHV) dysfunction is rare but potentially life-threatening. Although often challenging, establishing the exact cause of PHV dysfunction is essential to determine the appropriate treatment strategy. In clinical practice, a comprehensive approach that integrates several parameters of valve morphology and function assessed with 2D/3D transthoracic and transoesophageal echocardiography is a key to appropriately detect and quantitate PHV dysfunction. Cinefluoroscopy, multidetector computed tomography, cardiac magnetic resonance imaging, and to a lesser extent, nuclear imaging are complementary tools for the diagnosis and management of PHV complications. The present document provides recommendations for the use of multimodality imaging in the assessment of PHVs.
No takes yet. Share an insight, caveat, or question.
Lancellotti et al. (2016) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: